[1]
2026. A PROSPECTIVE STUDY OF CONTRASTING PERFORMANCE OF MITOMYCIN-C INSTILLATION IN A SINGLE SESSION TO THAT OF SIX SESSIONS IN PATIENTS WITH LOW-RISK, NON-MUSCLE-INVASIVE BLADDER CANCER. Eureka Journal of Health Sciences & Medical Innovation. 2, 5 (May 2026), 271–291.